Papers - MISAKA Shingen
-
Role of (―)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe Osamu, Ono Tomoyuki, Sato Hideyuki, Müller Fabian, Ogata Hiroshi, Miura Itaru, Shikama Yayoi, Yabe Hirooki, Onoue Satomi, Fromm Martin F, Kimura Junko, Misaka Shingen
European Journal of Clinical Pharmacology 2018.2
-
Update of green tea interactions with cardiovascular drugs and putative mechanisms
José P. Werba, Shingen Misaka, Monica Gianna Giroli, Kenju Shimomura, Manuela Amatoa, Niccolò Simonelli, Lorenzo Vigoa, Elena Tremoli
Journal of Food and Drug Analysis 2018.2
-
Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Shingen Misaka, Osamu Abe, Hideyuki Sato, Tomoyuki Ono, Yayoi Shikama, Satomi Onoue, Hirooki Yabe, Junko Kimura
European Journal of Clinical Pharmacology 74 ( 5 ) 601 - 609 2018
-
The non-metabolized β-blocker nadolol is a substrate of OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein, but not of OATP1B1 and OATP1B3
Shingen Misaka, Jana Knop, Katrin Singer, Eva Hoier, Markus Keiser, Fabian Müller, Hartmut Glaeser, Jörg König, Martin F. Fromm
Molecular Pharmaceutics 13 512 - 519 2016
-
Inhibitory effects of green tea and (-)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein.
Jana Knop, Shingen Misaka, Katrin Singer, Eva Hoier, Fabian Müller, Hartmut Glaeser, Jörg König, Martin F. Fromm
Plos One 10 ( 10 ) e0139370 2015.10
-
Overview of green tea interaction with cardiovascular drugs.
Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H.
Current Pharmaceutical Design 21 1213 - 1219 2015
-
Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects.
Shingen Misaka, Junichi Yatabe, Fabian Müller, Kozue Takano, Keisuke Kawabe, Hartmut Glaeser, Midori S. Yatabe, Satomi Onoue, José P. Werba, Hiroshi Watanabe, Shizuo Yamada, Martin F. Fromm, Junko Kimura
Clinical Pharmacology & Therapeutics 95 ( 4 ) 432 - 438 2014
-
Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Shingen Misaka, Nozomu Miyazaki, Tetsuhito Fukushima, Shizuo Yamada, Junko Kimura
Phytomedicine 20 ( 14 ) 1247 - 1250 2013
-
Clinical relevance of drug efflux pumps in the gut.
Shingen Misaka, Fabian Müller, Martin F. Fromm
Current Opinion in Pharmacology 13 847 - 852 2013
-
Pharmacokinetic and pharmacodynamic interactions of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers.
Shingen Misaka, Nozomu Miyazaki, Midori S. Yatabe, Tomoyuki Ono, Yayoi Shikama, Tetsuhito Fukushima, Junko Kimura
Journal of Clinical Pharmacology 53 ( 7 ) 738 - 745 2013
-
Effects of itraconazole, dexamethasone and naringin on pharmacokinetics of nadolol in rats.
Nozomu Miyazaki, Shingen Misaka, Hiroshi Ogata, Tetsuhito Fukushima, Junko Kimura
Drug Metabolism and Pharmacokinetics 28 ( 4 ) 356 - 361 2013
-
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
Shingen Misaka, Keisuke Kawabe, Satomi Onoue, José P. Werba, Monica Giroli, Sekihiro Tamaki, Toshiyuki Kan, Junko Kimura, Hiroshi Watanabe, Shizuo Yamada
Drug Metabolism and Pharmacokinetics 28 ( 3 ) 244 - 249 2013
-
Green tea extract affects cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats.
Shingen Misaka, Keisuke Kawabe, Satomi Onoue, Monica Giroli, José P. Werba, Hiroshi Watanabe, Shizuo Yamada
Drug Metabolism and Pharmacokinetics 28 ( 6 ) 514 - 518 2013
-
Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis
Shingen Misaka, Hideyuki Sato, Yosuke Aoki, Takahiro Mizumoto, Satomi Onoue, Shizuo Yamada
Peptides 32 401 - 407 2011
-
Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R15, 20, 21, L17, A24,25, des-N28]-VIP-GRR) in experimental asthma/COPD model rats
Satomi Onoue, Yosuke Aoki, Takuya Matsui, Yoshiki Kojo, Shingen Misaka, Takahiro Mizumoto, Shizuo Yamada
International Journal of Pharmaceutics 410 54 - 60 2011
-
Evaluation of pharmacodynamic interaction of midazolam with ursodeoxycholic acid, ketoconazole and dexamethasone by brain benzodiazepine receptor occupancy
Shingen Misaka, Souhei Kurosawa, Shinya Uchida, Akira Yoshida, Yoshihisa Kato, Yoshiyuki Kagawa, Shizuo Yamada
Journal of Pharmacy and Pharmacology 63 58 - 64 2011
-
Benzbromarone pharmacokinetics and pharmacodynamics in different cytochrome P450 2C9 genotypes
Shinya Uchida, Kayoko Shimada, Shingen Misaka, Hiromitsu Imai, Naoki Inui, Kazuhiko Takeuchi, Noriyuki Namiki, Takashi Ishizaki, Kyoichi Ohashi, Shizuo Yamada, Hiroshi Watanabe
Drug Metabolism and Pharmacokinetics 25 605 - 610 2010
-
Effects of a stabilized vasoactive intestinal peptide derivative, [R15, 20, 21, L17]-VIP-GRR (IK312532), on cigarette smoke-induced lung inflammation in rats
Satomi Onoue, Shingen Misaka, Yosuke Aoki, Shin-ichiro Karaki, Atsukazu Kuwahara, Takahiro Mizumoto, Shizuo Yamada
European Journal of Pharmaceutical Sciences 41 508 - 514 2010
-
Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: Anti-inflammatory effect in experimental asthmatic rats
Shingen Misaka, Yosuke Aoki, Shin-ichiro Karaki, Atsukazu Kuwahara, Takahiro Mizumoto, Satomi Onoue, Shizuo Yamada
Peptides 31 72 - 78 2010
-
Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets.
Hattori K, Shimizu M, Yamachi M, Tezuka K, Fukushima T, Yokota S, Okano T, Misaka S, Hidema S, Kanai K, Shimomura K, Maejima Y
Aging 17 ( 5 ) 1139 - 1147 2025.5